British drugmaker GSK said on Wednesday administration of its respiratory syncytial virus (RSV) vaccine and shingles shot ...
The new respiratory syncytial virus (RSV) vaccines recommended for individuals aged 60 years and older may provide individual and societal cost-savings benefits, a study suggests. 1 "We view this ...
Reformulated flu and COVID-19 shots are available to Oregonians starting this month. And an RSV vaccine — developed only last year — could have an unprecedented impact keeping infants out of ...
This summer, GSK cut its yearly vaccine sales projection on the back of a narrowed recommendation for adult respiratory syncytial virus (RSV) vaccines from the Centers for Disease Control and ...
Last year was the first year that the US had vaccines available to protect against all three major respiratory viruses — Covid-19, flu and RSV — but vaccine uptake was low for the season.
GSK has revised its annual vaccine sales forecast following new guidance on RSV from the CDC. But new evidence offers new ...
Topline results were announced from a phase 3 study assessing the immune response following coadministration of Arexvy and Shingrix.
With the arrival of new vaccines for respiratory syncytial virus (RSV), Canadian seniors are faced with a critical decision: Is it worth getting the shot, especially if it’s not covered by public ...
Pregnant women across Australia could be offered a free vaccine to protect their babies against respiratory syncytial virus (RSV) from next year. Health Minister Mark Butler has flagged the ...
reactogenicity and safety of Arexvy (Respiratory Syncytial Virus Vaccine) when co-administered with Shingrix (Zoster Vaccine). Shingrix is approved to prevent shingles (herpes zoster) in adults ...